Zhejiang Tailin Bioengineering Co Ltd (300813) — Cash Flow-to-Debt Ratio
Zhejiang Tailin Bioengineering Co Ltd (300813) has a Cash Flow-to-Debt Ratio of 0.27x as of December 2025, meaning its operating cash flow of CN¥42.25 Million could theoretically repay 0% of its total liabilities (CN¥155.04 Million) in one year. Check 300813 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Tailin Bioengineering Co Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zhejiang Tailin Bioengineering Co Ltd across 13 annual periods. Also explore Zhejiang Tailin Bioengineering Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)
Year-by-year debt coverage analysis for Zhejiang Tailin Bioengineering Co Ltd. For market capitalisation and broader financial context, see 300813 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | CN¥57.11 Million | CN¥155.04 Million | ▲ +107.9% |
| 2024 | 0.18x | CN¥24.66 Million | CN¥139.18 Million | ▲ +2864.5% |
| 2023 | 0.01x | CN¥1.93 Million | CN¥323.27 Million | ▼ -98.2% |
| 2022 | 0.32x | CN¥89.39 Million | CN¥275.21 Million | ▲ +43.1% |
| 2021 | 0.23x | CN¥35.96 Million | CN¥158.49 Million | ▼ -79.6% |
| 2020 | 1.11x | CN¥106.28 Million | CN¥95.75 Million | ▲ +44.5% |
| 2019 | 0.77x | CN¥29.04 Million | CN¥37.81 Million | ▲ +24.3% |
| 2018 | 0.62x | CN¥37.33 Million | CN¥60.42 Million | ▲ +26.3% |
| 2017 | 0.49x | CN¥23.04 Million | CN¥47.10 Million | ▼ -38.5% |
| 2016 | 0.80x | CN¥31.56 Million | CN¥39.66 Million | ▲ +9.6% |
| 2015 | 0.73x | CN¥24.54 Million | CN¥33.79 Million | ▼ -3.1% |
| 2014 | 0.75x | CN¥17.51 Million | CN¥23.35 Million | ▲ +11.1% |
| 2013 | 0.67x | CN¥11.51 Million | CN¥17.06 Million | — |